Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks
Upadacitinib治疗中重度特应性皮炎患者的疗效和安全性:3期随机临床试验140周结果
期刊:American Journal of Clinical Dermatology
影响因子:8.8
doi:10.1007/s40257-025-00975-3
Irvine, Alan D; Prajapati, Vimal H; Guttman-Yassky, Emma; Simpson, Eric L; Papp, Kim A; Blauvelt, Andrew; Chu, Chia-Yu; Hong, H Chih-Ho; Gold, Linda F Stein; de Bruin-Weller, Marjolein; Bieber, Thomas; Kabashima, Kenji; Rosmarin, David; Sancho, Cristina; Calimlim, Brian M; Grada, Ayman; Yang, Yang; Wu, Xiaoqiang; Levy, Gweneth; Raymundo, Eliza M; Teixeira, Henrique D; Silverberg, Jonathan I